Background and Format: Screentrade Magazine covers all aspects of Cinema Exhibition and Film Distribution. Screentrade also covers the industry from a trade perspective. Audience and Readership: The magazine is aimed at film distribution professionals. It is available through subscriptions. Time of Publication: The magazine is published in February, May, September and November.  Circulation: Source: Publisher Ad Rates: For information on ad rates, email advertising@screentrademagazine.com

Scriberia believes in the power of pictures to communicate ideas, tell stories and describe processes. Through animation, illustration, live and digital scribing and workshop facilitation, there award-winning team offers a fast, flexible, creative service.

Scribicide is a blog covering theater in New York. Offers insight on the latest news and reviews. The fundamentals of working with bloggers are the same as with traditional journalists at traditional media outlets: respect their schedules; take time to read their material to learn their interests; and only contact them if/when they want to be contacted. You will also find that if a blogger is a journalist for another outlet(s), Cision tracks their contact preferences there as well. This blog offers RSS (Really Simple Syndication).

By focusing on the strategic implications of global pharma news, Scrip supports timely and tactical decision making throughout the entire drug discovery, development, and product life cycle value chain. From biotech start-ups to multinational pharma giants, Scrip provides critical intelligence on the latest licensing opportunities, partnership deals, R&D activity, company developments and market access insights.

Background and Format: SCRIP Intelligence seeks to provide vital original pharmaceutical industry ideas and global signals for career, business and future planning. Customers receive a glimpse of the future from the daily drumbeat of crucial events across the sector spectrum – from biotech start-ups to multinational giants; research boutiques to generic manufacturers; and suppliers large and small. Experienced writers and analysts are based in key geographic markets to convey all aspects of the industry. Global hot topics such as orphan diseases, personalized medicine, and management strategies from developed to emerging markets are covered with local depth and insight. Audience and Readership: SCRIP has over 17,000 registered users consisting of mid-to-C-Level managers and executives working across all disciplines in pharmaceutical and biotech companies, worldwide (source Publisher). 100% of the world top 100 pharma companies subscribe to SCRIP. Their global reach includes subscribers in 85 countries.

Background and Format: SCRIP Intelligence seeks to provide vital original pharmaceutical industry ideas and global signals for career, business and future planning. Customers receive a glimpse of the future from the daily drumbeat of crucial events across the sector spectrum – from biotech start-ups to multinational giants; research boutiques to generic manufacturers; and suppliers large and small. Experienced writers and analysts are based in key geographic markets to convey all aspects of the industry. Global hot topics such as orphan diseases, personalized medicine, and management strategies from developed to emerging markets are covered with local depth and insight. In addition to their internal resources, SCRIP Intelligence reaches out to expert colleagues in other Informa businesses including Datamonitor, Citeline, Scrip Business Insights, Scrip Regulatory Affairs, Clinica and the Informa Healthcare journals. Audience and Readership: SCRIP has over 17,000 registered users consisting of mid-to-C-Level managers and executives working across all disciplines in pharmaceutical and biotech companies, worldwide (source Publisher). 100% of the world top 100 pharma companies subscribe to SCRIP. Their global reach includes subscribers in 85 countries. Circulation / MUU: SCRIP attracts 55,000 unique web visitors every month (source Publisher). Distribution: SCRIP Intelligence is available in a variety of formats, including online, mobile, email, podcasts and video. This includes daily and a weekly email alerts. Ad rates: For further information visit http://advertising.scripintelligence.com/

Background and Format: SCRIP Intelligence seeks to provide vital original pharmaceutical industry ideas and global signals for career, business and future planning. Customers receive a glimpse of the future from the daily drumbeat of crucial events across the sector spectrum – from biotech start-ups to multinational giants; research boutiques to generic manufacturers; and suppliers large and small. Experienced writers and analysts are based in key geographic markets to convey all aspects of the industry. Global hot topics such as orphan diseases, personalized medicine, and management strategies from developed to emerging markets are covered with local depth and insight. In addition to their internal resources, SCRIP Intelligence reaches out to expert colleagues in other Informa businesses including Datamonitor, Citeline, Scrip Business Insights, Scrip Regulatory Affairs, Clinica and the Informa Healthcare journals.   Audience and Readership: SCRIP has over 17,000 registered users consisting of mid-to-C-Level managers and executives working across all disciplines in pharmaceutical and biotech companies, worldwide (Source Publisher). 100% of the world top 100 pharma companies subscribe to SCRIP. Their global reach includes subscribers in 85 countries. Distribution: SCRIP Intelligence is available in a variety of formats, including online, mobile, email, podcasts and video. This includes daily and a weekly email alerts.  

Scrip Pharma Intelligence is an online portal providing around-the-clock news and analysis on regulatory, legal and financial developments affecting pharmaceutical, biologics and medical device manufacturers doing business in China, India, Japan and other nations of the Pacific Rim. The editorial team of Scrip Pharma Intelligence has access to a comprehensive network of insiders in industry, government and the investment community. Scrip Pharma Intelligence aims to provide highly specialized industry insight on the Asian marketplace, plus editor's picks from the world press and English summaries of Chinese and Japanese news. PharmAsia News is read by Pharma, biotech and device professionals looking for high-quality coverage of business and regulatory developments in the Pacific Rim rely on PharmAsia News to help them monitor rapidly-changing events first-hand; anticipate regulatory and safety developments (Healthcare Policy); reduce the risk of corruption violations; and understand local business customs.

Scripps News, formerly Newsy, delivers compelling, context-driven news, fact-based reporting, and a deeper look at the at the "why" of each story with objective, impactful storytelling.

The Scripps News Washington Bureau provides national investigative stories for Scripps-owned television stations including ABC, NBC, CBS, and Fox affiliates, also producing the political podcast DecodeDC.com.